Haolin Jiang

Learn More
Cisplatin resistance remains one of the major obstacles when treating epithelial ovarian cancer. Because oxaliplatin and nedaplatin are effective against cisplatin-resistant ovarian cancer in clinical trials and signal transducer and activator of transcription 3 (STAT3) is associated with cisplatin resistance, we investigated whether overcoming cisplatin(More)
ACKNOWLEDGEMENT I would like to express my deepest gratitude to my mentor, Dr. Reid Gilmore. His insightful advice and constant encouragement guided me through my graduate research. I was always inspired by his intelligence and dedication to the work. I want to thank specially my husband, Zhiliang Cheng, for his love and support. He has been my best friend(More)
  • 1